Original research
par
Seaman, Andrew et al
Date de publication
2024
Géographie
USA
Langue de la ressource
English
Texte disponible en version intégrale
Non
Open Access / OK to Reproduce
Non
Évalué par des pairs
Yes
L’objectif
Hepatitis C virus (HCV) elimination requires treating people who use drugs (PWUD), yet <10% of PWUD in the United States access HCV treatment; access is especially limited in rural communities.
Constatations/points à retenir
The Peer TeleHCV treatment model substantially increased HCV treatment initiation and viral clearance compared to EUC.
La conception ou méthodologie de recherche
We randomized PWUD with HCV viremia and past 90-day injection drug or nonprescribed opioid use in 7 rural Oregon counties to peer-assisted telemedicine HCV treatment (TeleHCV) versus peer-assisted referral to local providers (enhanced usual care [EUC]). Generalized linear models estimated group differences in HCV viral clearance (primary outcome) and HCV treatment initiation and completion (secondary outcomes).
Mots clés
Barriers and enablers
Evidence base
Injecting drugs
Harm reduction
Peer/PWLLE program involvement
Rural/remote
Wrap-around services
